Optimizing retention, duration & discontinuation strategies for opioid use disorder pharmacotherapy (CTN-0100). 03/01/2020 - 08/15/2022. N01DA-19-2250.task order 75N95020F00002 (TO13).
Ended Awarded Last action
- Contract number
- 75N95020F00002
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,122,596
Award facts
- Opportunity
-
- TORFP75N95020F00002 Solicitation number
- Contract value 100% obligated
- $3,122,596.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,350,572 | |
| Other Administrative Action | $0 | |
| Original award | $1,772,024 |
About this award
The Emmes Company LLC has been awarded a $3.1 million cost-plus-fixed-fee delivery order to support the National Institute on Drug Abuse's Clinical Trials Network. Under task order 75N95020F00002 (TO13) issued against the NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER indefinite delivery/indefinite quantity contract vehicle, Emmes will optimize retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy as part of Clinical Trials Network study CTN-0100. Work will be performed in Potomac, Maryland through February 2026. The award provides expertise to assist NIDA's efforts developing more effective treatment options for those suffering from opioid addiction.
Quick answers
Who was awarded contract 75N95020F00002?
75N95020F00002 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on March 1, 2020.
How much is contract 75N95020F00002 worth?
The government has obligated $3,122,596 on 75N95020F00002.
Is contract 75N95020F00002 an order under another contract?
Yes. 75N95020F00002 is a delivery order under 75N95019D00013, an indefinite delivery contract.
Was contract 75N95020F00002 competed?
The extent of competition for 75N95020F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award